From Patient Tumors to Causal Biology
An integrated, end-to-end capability that provisions human tumors through to multi-modal analysis and clinical correlation, creating a rich and reusable resource for drug discovery and AI oncology.
Established Scale. Growing Impact.
24,000+
Tumors processed over 10+ years
~10,000
Perturbed tissue states
80+
Treatments and combinations
20+
Clinical partners
AACR Annual Meeting 2026
Integrated tumor histoculture and same-cell spatial multiomicslink biosignatures to immune checkpoint blockade responses in head and neck cancer
AACR Annual Meeting 2026
Tertiary Lymphoid Structure (TLS) representative cells elicit response to anti-PD-1+ therapy in a cold tumor
Drug Development Solutions
We partner with biopharma, academic and clinical organizations to generate high-quality, biologically relevant tumor data for drug discovery, translational research and biomarker development.
Drug response and resistance mechanisms
Biomarker discovery and validation
Patient stratification
Combination strategies
AI Oncology Solutions
We partner with AI labs, techbios, and AI-focused biotechs to build predictive AI systems grounded in real human tumor biology.
Digital Tumor Twins
AI model validation
Target discovery & confirmation
Response & resistance model training